DESMOPRESSIN
Stock to watch: Shilpa Medicare stock in focus after receiving CEP from EDQM for diabetes drugShares of Shilpa Medicare will be highlighted as its subsidiary, Shilpa Pharma Lifesciences, obtained a certificate of suitability from Eur...
Glenmark gets USFDA nod for generic diabetes treatment drugGlenmark's current portfolio consists of 97 products authorised for distribution in the US and 68 abbreviated new drug approvals with the U...
- Load More